Relationship of soluble RAGE with insulin resistance and beta cell function during development of type 2 diabetes mellitus

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Biswas, Subrata Kumar ^a   Mohtarin, Sabreena ^a   Mudi, Sonchita Rani ^b   Anwar, Taznuva ^a   Banu, Laila Anjuman ^a   Alam, Sheikh Md Khorshed ^a   Fariduddin, Md ^a   Arslan, M Iqbal ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; SRAGE PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; ANALYSIS; BANGLADESH; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; MASS SCREENING; METABOLISM; MIDDLE AGED; RISK; SECRETION (PROCESS); STATISTICAL MODEL; YOUNG ADULT;

ADULT; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; BANGLADESH; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LINEAR MODELS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; RISK; YOUNG ADULT;

EID: 84930939583     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/150325     Document Type: Article

References (22)

1. A. Bierhaus, P. M. Humpert, M. Morcos et al., "Understanding RAGE, the receptor for advanced glycation end products, " Journal ofMolecularMedicine, vol. 83, no. 11, pp. 876-886, 2005.
2. H. Yonekura, Y. Yamamoto, S. Sakurai et al., "Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury, " Biochemical Journal, vol. 370, no. 3, pp. 1097-1109, 2003.
3. A. Raucci, S. Cugusi, A. Antonelli et al., "A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10), " The FASEB Journal, vol. 22, no. 10, pp. 3716-3727, 2008.
4. Y. Chen, S. S. Yan, J. Colgan et al., "Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products, " Journal of Immunology, vol. 173, no. 2, pp. 1399-1405, 2004.
5. J. Han, J. Zhong, W. Wei et al., "Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice, " Diabetes, vol. 57, no. 8, pp. 2118-2127, 2008.
6. C. M. Sullivan, T. S. Futers, J. H. Barrett, B. I. Hudson, M. S. Freeman, and P. J. Grant, "RAGE polymorphisms and the heritability of insulin resistance: the Leeds Family Study, " Diabetes and Vascular Disease Research, vol. 2, no. 1, pp. 42-44, 2005.
7. J. M. Forbes, J. Soderlund, F. Y. T. Yap et al., "Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes, " Diabetologia, vol. 54, no. 5, pp. 1032-1042, 2011.
8. K. M. Salonen, S. J. Ryhaenen, J. M. Forbes et al., "Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes, " Diabetes Care, vol. 38, no. 4, pp. 665-670, 2015.
9. E. Selvin, M. K. Halushka, and A. M. Rawlings, "sRAGE and risk of diabetes, cardiovascular disease, and death, " Diabetes, vol. 62, pp. 2116-2121, 2013.
10. American Diabetes Association, "Diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 36, supplement 1, pp. S67-S74, 2013.
11. S. I. Yamagishi and T. Matsui, "Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker, " Frontiers in Bioscience, vol. 2, no. 4, pp. 1184-1195, 2010.
12. S. K. Biswas, S. R. Mudi, F. H. Mollah, A. Bierhaus, and M. I. Arslan, "Serum soluble receptor for advanced glycation end products (sRAGE) is independently associated with cigarette smoking in non-diabetic healthy subjects, " Diabetes and Vascular Disease Research, vol. 10, no. 4, pp. 380-382, 2013.
13. K. M. Salonen, S. J. Ryhaenen, J. M. Forbes et al., "Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes, " Diabetes Care, vol. 37, pp. 1975-1981, 2014.
14. A. Di Pino, R. Scicali, S. Calanna et al., "Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA1c according to American Diabetes Association criteria, " Diabetes Care, vol. 37, no. 5, pp. 1447-1453, 2014.
15. G. Basta, A. M. Sironi, G. Lazzerini et al., "Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein, " The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4628-4634, 2006.
16. T. Henle, "Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods, " Amino Acids, vol. 29, no. 4, pp. 313-322, 2005.
17. H. Kaneto, J. Fujii, T. Myint et al., "Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction, " Biochemical Journal, vol. 320, no. 3, pp. 855-863, 1996.
18. T.-A. Matsuoka, Y. Kajimoto, H. Watada et al., "Glycationdependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells, " Journal of Clinical Investigation, vol. 99, no. 1, pp. 144-150, 1997.
19. M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, and H. Vlassara, "Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice, " Diabetes, vol. 52, no. 6, pp. 1441-1448, 2003.
20. J. W. M. Nin, A. Jorsal, I. Ferreira et al., "Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and allcause mortality in type 1 diabetes: a 12-year follow-up study, " Diabetes, vol. 59, no. 8, pp. 2027-2032, 2010.
21. R. D. Semba, L. Ferrucci, K. Sun et al., "Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women, " Aging Clinical and Experimental Research, vol. 21, no. 2, pp. 182-190, 2009.
22. S.-I. Yamagishi, "Comment on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121, " Diabetes, vol. 62, no. 10, article e26, 2013.